We've found
184,457
clinical trials
We've found
184,457
clinical trials
Advanced Solid Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Advanced Solid Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
Senescence in Chronic Kidney Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Autism Spectrum Disorders Clinical Trial
Updated: 12/31/1969
Single Dose Intranasal Oxytocin and Cognitive Effects in Autism
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (≥65 Years) AML Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (≥65 Years) AML Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cannabis Intoxication Clinical Trial
Updated: 5/1/2018
Using a Field Performance Test on an iPad to Evaluate Driving Under the Influence of Cannabis
Status: Enrolling,
Phase
II, III
Updated: 5/1/2018
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics and Activity of K0706
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Blepharospasm Tools
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials

Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials

Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials

Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials

Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
Updated: 4/9/2018
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
Status: Enrolling,
Phase
Updated: 4/9/2018
Click here to add this to my saved trials

Carcinoma Breast Stage IV Clinical Trial
Updated: 12/31/1969
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Bacterial Infections Clinical Trial
Updated: 12/31/1969
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Bacterial Infections Clinical Trial
Updated: 12/31/1969
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Bacterial Infections Clinical Trial
Updated: 12/31/1969
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Triple Negative Breast Cancer (TNBC) Clinical Trial
Updated: 4/26/2018
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling,
Phase
III
Updated: 4/26/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced or Metastatic Non-HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurological Observations Clinical Trial
Updated: 1/15/2018
Additional Post Hoc Analysis and Clinical Data Collection
Status: Enrolling
Updated: 1/15/2018
Click here to add this to my saved trials

Lymphoma Clinical Trial
Updated: 12/31/1969
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Lymphoma Clinical Trial
Updated: 12/31/1969
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Pancreatic Cancer Clinical Trial
Updated: 4/23/2018
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials

Pancreatic Cancer Clinical Trial
Updated: 4/23/2018
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials

Pancreatic Cancer Clinical Trial
Updated: 4/23/2018
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials

Pancreatic Cancer Clinical Trial
Updated: 4/23/2018
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Status: Enrolling,
Phase
II
Updated: 4/23/2018
Click here to add this to my saved trials

Musculoskeletal Clinical Trial
Updated: 8/10/2016
IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
Status: Enrolling,
Phase
IV
Updated: 8/10/2016
Click here to add this to my saved trials

Restless Legs Syndrome (RLS) Clinical Trial
Updated: 12/31/1969
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Restless Legs Syndrome (RLS) Clinical Trial
Updated: 12/31/1969
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Diabetes Clinical Trial
Updated: 8/10/2016
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/10/2016
Click here to add this to my saved trials

Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Type 1 Diabetes Mellitus Clinical Trial
Updated: 8/11/2016
Bigfoot Biomedical Clinical Research Center (CRC) Trial
Status: Enrolling,
Phase
I
Updated: 8/11/2016
Click here to add this to my saved trials

Type 1 Diabetes Mellitus Clinical Trial
Updated: 8/11/2016
Bigfoot Biomedical Clinical Research Center (CRC) Trial
Status: Enrolling,
Phase
I
Updated: 8/11/2016
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Gastroenterology, Musculoskeletal, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
Updated: 1/10/2018
Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 1/25/2018
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling,
Phase
II, III
Updated: 1/25/2018
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 1/25/2018
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling,
Phase
II, III
Updated: 1/25/2018
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 1/25/2018
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling,
Phase
II, III
Updated: 1/25/2018
Click here to add this to my saved trials

Adenomyosis Clinical Trial
Updated: 8/16/2016
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling,
Phase
II
Updated: 8/16/2016
Click here to add this to my saved trials

Adenomyosis Clinical Trial
Updated: 8/16/2016
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling,
Phase
II
Updated: 8/16/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
